Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;47:818-819
Published online before print April 3, 2006, doi: 10.1161/01.HYP.0000217130.01867.4b
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/5/818    most recent
01.HYP.0000217130.01867.4bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sert Kuniyoshi, F. H.
Right arrow Articles by Somers, V. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sert Kuniyoshi, F. H.
Right arrow Articles by Somers, V. K.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
*Sleep Apnea
Related Collections
Right arrow Other Treatment
Right arrowRelated Article

(Hypertension. 2006;47:818.)
© 2006 American Heart Association, Inc.


Editorial Commentaries

Sleep Apnea in Hypertension

When, How, and Why Should We Treat?

Fatima H. Sert Kuniyoshi; Virend K. Somers

From the Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, 200 First St, SW, Rochester, Minn.

Correspondence to Virend K. Somers, Mayo Clinic, 200 First St, SW, Rochester, MN 55902. E-mail somers.virend@mayo.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Hypertension is a notoriously complex disease, with a mosaic of potential interactive etiologies. Age, gender, nutrition, environment, stress, obesity, and genetics have been cited as causal factors, as has been dysfunction in renal, endocrine, and neural circulatory control mechanisms. More recently, the epidemic of obesity has prompted recognition of an interaction between obstructive sleep apnea and increased blood pressure. This has, in turn, provided an exciting opportunity for more comprehensive understanding of the pathophysiological mechanisms and potential treatment strategies for hypertensive patients.

Both hypertension and obstructive sleep apnea (OSA) are each increasingly common. Hypertension is present in well over a third of middle-aged subjects, and sleep apnea is reported to be present in 25% of middle-aged men and 10% of middle-aged women.1 Other common characteristics of hypertension and OSA include their association with obesity and male gender. Furthermore, both conditions are often clinically undiagnosed and may be accompanied by increased risk of cardiac and vascular damage.

Although hypertension and OSA are common in the general population, epidemiological studies suggest that their comorbid prevalence exceeds strikingly that which would be anticipated to occur by chance alone. These observations, based on cross-sectional data, have been further strengthened by prospective studies demonstrating that increasing severity of OSA is a risk factor for the development of incident hypertension over 4 years.2 This etiologic interaction is independent of traditional risk factors for hypertension, such as alcohol, body mass index, and gender. Also impressive is that an apnea-hypopnea index of ≥15 (indicating that breathing decreases or . . . [Full Text of this Article]


Related Article:

Effects of Continuous Positive Airway Pressure Versus Supplemental Oxygen on 24-Hour Ambulatory Blood Pressure
Daniel Norman, José S. Loredo, Richard A. Nelesen, Sonia Ancoli-Israel, Paul J. Mills, Michael G. Ziegler, and Joel E. Dimsdale
Hypertension 2006 47: 840-845. [Abstract] [Full Text] [PDF]